BIOLOGICAL · Unmapped registry intervention
recombinant human chorionic gonadotropin
Find medicine records ·
Find other trials using this name
Clinical trial
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
NCT00700778
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
GENETIC · Unmapped registry intervention
microarray analysis
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
immunohistochemistry staining method
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
needle biopsy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRecombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
BRCA1 Mutationunresolved
Breast Cancerverified · MONDO: breast cancer
Interventions
Sponsors & collaborators
Fox Chase Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00700778 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.